|
CLOPAMIDE | |||
PRODUCT IDENTIFICATION |
|||
CAS NO. | 636-54-4 |
|
|
EINECS NO. | 211-261-7 | ||
FORMULA | C14H20ClN3O3S | ||
MOL WT. | 345.85 | ||
H.S. CODE |
|||
TOXICITY |
|||
DERIVATION |
|
||
CLASSIFICATION |
|
||
SYNONYMS | Aquex; Clopamida; Clopamide; Clopamidum; | ||
4-Chloro-N-[(2R,6S)-2,6-dimethylpiperidin-1-yl]-3-sulfamoylbenzamide; cis-3-(aminosulfonyl)-4-chloro-N-(2,6-dimethyl-1-piperidinyl)benzamide; Clopamide; 4-Chloro-N-(cis-2,6-dimethylpiperidino)-3-sulfamoylbenzamide; 4-Chloro-N-(2,6-dimethylpiperidino)-3-sulfamoylbenzamide; | |||
PHYSICAL AND CHEMICAL PROPERTIES |
|||
PHYSICAL STATE | White to yellowish crystalline powder | ||
MELTING POINT | |||
BOILING POINT |
|
||
SPECIFIC GRAVITY |
|
||
SOLUBILITY IN WATER | |||
pH | |||
VAPOR DENSITY | |||
AUTOIGNITION |
|
||
NFPA RATINGS |
|||
REFRACTIVE INDEX |
|
||
FLASH POINT |
|
||
STABILITY | Stable under ordinary conditions. | ||
APPLICATIONS |
|||
Clopamide has piperidine moiety and is classified as a sulfamoyl diuretic. It has similar properties
to thiazide class diuretics which act on the inhibiting reabsorption of sodium in the proximal
renal tubule and stimulating chloride excretion, resulting in increasing excretion of water. Clopamide
is used in the treatment of edema due to
congestive heart failure or chronic hepatic or renal disease
associated with various disorders and in hypertension.
Class of diuretics are:
|
|||
SALES SPECIFICATION | |||
APPEARANCE | White to yellowish crystalline powder | ||
IDENTIFICATION |
pass Test |
||
ASSAY |
98.0 - 102.0 % | ||
MELTING POINT |
230 - 232 C |
||
LOSS ON DRYING |
2.5% max |
||
SULFATED ASH |
0.2% max |
||
HEAVY METALS |
20ppm max |
||
TRANSPORTATION | |||
PACKING |
|
||
HAZARD CLASS | |||
UN NO. | |||
PRICES | |||
|
|